All In Biotech

Drug Trial Radar · NCT00054613

Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease

A Randomized Single-Blind Study of Extracorporeal Photoimmune Therapy With UVADEX in Conjunction With Standard Therapy Alone for the Treatment of Patients With Corticosteroid-Refractory, Corticosteroid-Dependent, or Corticosteroid-Intolerant Chronic Graft-versus-Host Disease

Last checked: Nov 20, 2026Latest source record: Aug 16, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

72

Actual

Start

Jun 2002

Primary completion

Not stated

Study completion Mar 2004

Sponsor

Lead sponsor
MallinckrodtIndustry
Sponsor type
Industry
First posted
Feb 6, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Single
Primary purpose
Treatment
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether extracorporeal photoimmune therapy with UVADEX (ECP) added to standard therapy is effective in the treatment of chronic graft-versus-host disease (GvHD).

Conditions

  • Graft-versus-Host Disease

Interventions

  • MethoxsalenDrug

  • Extracorporeal PhotopheresisProcedure

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

31 sites in 12 countries. Site status is shown where the registry gives one.

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • University of Florida

    Gainesville, Florida

  • Rush Presbyterian - St. Lukes Medical Center

    Chicago, Illinois

  • University of Chicago

    Chicago, Illinois

  • Tufts New England Medical Center

    Boston, Massachusetts

  • Brigham and Womens

    Boston, Massachusetts

  • University of Michigan

    Ann Arbor, Michigan

  • Kansas City Cancer Center

    Kansas City, Missouri

  • University of Nebraska

    Omaha, Nebraska

  • Jewish Hospital

    Cincinnati, Ohio

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington

  • Peter MacCallum

    East Melbourne, Australia

  • Alfred Hospital

    Melbourne, Australia

  • Royal Melbourne Hospital

    Parkville, Australia

  • St. Vincent's Hospital

    Darlinghurst, New South Wales, Australia

  • General Hospital of Vienna

    Vienna, Austria

  • Hopital Edouard Herriot

    Lyon, France

  • Hopital Pitie-Salpetriere

    Paris, France

  • University of Dresden

    Dresden, Germany

  • Universitatis Hautklinik

    Essen, Germany

  • Universitatsklinikum Leipzig AOR

    Leipzig, Germany

  • Ludwig-Maximilians-Universitaet Muenchen

    München, Germany

  • Careggi Hospital

    Florence, Italy

  • San Martino Hospital

    Genova, Italy

  • Instituto Portugues de Oncologia de Francisco Gentil

    Lisbon, Portugal

  • Klinika hematologie a transfuziologie FN

    Bratislava, Slovakia

  • Hospital dela Santa Creu i Sant Pau. Universitat Autonoma de Barcelona

    Barcelona, Spain

  • Kantonsspital Basel

    Basel, Switzerland

  • Ankara University Medical School

    Altındağ, Ankara, Turkey (Türkiye)

  • Glasgow Royal Infirmary

    Glasgow, United Kingdom

  • Rotherham General Hospital

    Rotherham, Yorkshire, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.